0 التعليقات
0 المشاركات
266 مشاهدة
0 معاينة
البحث
إكتشاف أشخاص جدد وإنشاء اتصالات جديدة وصداقات جديدة
-
الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
-
GLP-1 Agonists Weight Loss Drugs Market Supply Chain AnalysisThe global GLP-1 Agonists Weight Loss Drugs Market was valued at USD 13.8 billion in 2024 and is projected to grow from USD 27.5 billion in 2026 to USD 48.8 billion by 2030, registering a CAGR of 18.5% from 2025 to 2030. North America dominated the market with a 75.5% revenue share in 2024, supported by high obesity prevalence, favorable reimbursement policies, strong pharmaceutical...0 التعليقات 0 المشاركات 615 مشاهدة 0 معاينة
-
GLP-1 Receptor Agonists Obesity Drugs Market: Insights, Key Players, and Growth AnalysisAccording to the latest report published by Data Bridge Market Research, the GLP-1 Receptor Agonists Obesity Drugs Market CAGR Value The global GLP-1 receptor agonists obesity drugs market size was valued at USD 9.96 billion in 2024 and is expected to reach USD 33.12 billion by 2032, at a CAGR of 16.21% during the forecast period Attaining...0 التعليقات 0 المشاركات 388 مشاهدة 0 معاينة
-
GLP-1 Receptor Agonists Obesity Drugs Market: Insights and Competitive AnalysisFuture of Executive Summary GLP-1 Receptor Agonists Obesity Drugs Market: Size and Share Dynamics CAGR Value The global GLP-1 receptor agonists obesity drugs market size was valued at USD 9.96 billion in 2024 and is expected to reach USD 33.12 billion by 2032, at a CAGR of 16.21% during the forecast period This GLP-1 Receptor Agonists Obesity Drugs Market...0 التعليقات 0 المشاركات 356 مشاهدة 0 معاينة
-
GLP-1 Receptor Agonists Obesity Drugs Market: Insights, Key Players, and Growth AnalysisAccording to the latest report published by Data Bridge Market Research, the GLP-1 Receptor Agonists Obesity Drugs Market CAGR Value The global GLP-1 receptor agonists obesity drugs market size was valued at USD 9.96 billion in 2024 and is expected to reach USD 33.12 billion by 2032, at a CAGR of 16.21% during the forecast period With the...0 التعليقات 0 المشاركات 291 مشاهدة 0 معاينة
-
GLP-1 Receptor Agonists Obesity Drugs Market: Insights, Key Players, and Growth AnalysisAccording to the latest report published by Data Bridge Market Research, the GLP-1 Receptor Agonists Obesity Drugs Market CAGR Value The global GLP-1 receptor agonists obesity drugs market size was valued at USD 9.96 billion in 2024 and is expected to reach USD 33.12 billion by 2032, at a CAGR of 16.21% during the forecast period This...0 التعليقات 0 المشاركات 251 مشاهدة 0 معاينة
-
GLP-1 Receptor Agonists Obesity Drugs Market: Insights, Key Players, and Growth AnalysisAccording to the latest report published by Data Bridge Market Research, the GLP-1 Receptor Agonists Obesity Drugs Market The global GLP-1 receptor agonists obesity drugs market size was valued at USD 9.96 billion in 2024 and is expected to reach USD 33.12 billion by 2032, at a CAGR of 16.21% during the forecast period CAGR Value With a...0 التعليقات 0 المشاركات 312 مشاهدة 0 معاينة
-
Long-Acting Implantable GLP-1 Obesity Devices Market Growth, In depth Studies with Top Vendors Analysis By FMINEWARK, DE |—The long-acting implantable GLP-1 obesity devices market is valued at USD 59.1 million in 2025 and is projected to reach USD 76.0 million in 2026. Expanding at a robust CAGR of 28.50%, the market is expected to surge to USD 932.9 million by 2036. This growth reflects a fundamental shift in obesity care delivery, as stakeholders prioritize long-term therapy...0 التعليقات 0 المشاركات 403 مشاهدة 0 معاينة
-
Therapeutic Radiopharmaceuticals MarketPotential: Size, Share, Trends, and Future Outlook"Future of Executive Summary GLP-1 Analogues Market: Size and Share Dynamics The global GLP-1 analogues market size was valued at USD 32.19 billion in 2024 and is expected to reach USD 346.06 billion by 2032, at a CAGR of 34.56% during the forecast period To thrive in this rapidly transforming marketplace, today’s businesses call for innovative and...0 التعليقات 0 المشاركات 794 مشاهدة 0 معاينة
-
Diabetes Treatments Market Size, Share, and Growth Forecast to 2030According to the latest report published by Data Bridge Market Research, the Diabetes Treatments Market Data Bridge Market Research analyses that the global diabetes treatments market which was USD 5,370.2 million in 2022, would rocket up to USD 8,920.9 million by 2030, and is expected to undergo a CAGR of 6.5 % during the forecast period. Type-1 segment dominates the type segment of...0 التعليقات 0 المشاركات 6كيلو بايت مشاهدة 0 معاينة
-
GLP-1 Market: Research Advancements and Industry DevelopmentsThe GLP-1 Market is expanding as therapeutic applications move beyond diabetes into obesity and cardiovascular disease. Valued at USD 52.82 billion in 2025, the GLP-1 Market is projected to reach USD 58.48 billion in 2026 and USD 133.92 billion by 2034, growing at a CAGR of 10.9% during the forecast period 2026–2034. Key players include AstraZeneca, Boehringer Ingelheim, D&D...0 التعليقات 0 المشاركات 81 مشاهدة 0 معاينة
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Bengali